CalciMedica, Inc. financial data

Symbol
CALC on Nasdaq
Location
La Jolla, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 03 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 471% % -10%
Debt-to-equity 623% % 1046%
Return On Equity -1173% % -1067%
Return On Assets -162% % -149%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 15,743,916 shares 17%
Common Stock, Shares, Outstanding 15,437,410 shares 15%
Entity Public Float $15,700,000 USD -44%
Common Stock, Value, Issued $4,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 15,011,321 shares 33%
Weighted Average Number of Shares Outstanding, Diluted 15,011,321 shares 33%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $15,234,000 USD 5.2%
General and Administrative Expense $7,887,000 USD -19%
Operating Income (Loss) $23,121,000 USD 4.5%
Nonoperating Income (Expense) $6,441,000 USD -161%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $29,562,000 USD -116%
Earnings Per Share, Basic -1.97 USD/shares -61%
Earnings Per Share, Diluted -1.97 USD/shares -61%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $11,520,000 USD 45%
Cash, Cash Equivalents, and Short-term Investments $13,000,000 USD -30%
Assets, Current $13,530,000 USD -31%
Property, Plant and Equipment, Net $50,000 USD -58%
Assets $13,591,000 USD -31%
Accounts Payable, Current $1,161,000 USD -42%
Liabilities, Current $3,782,000 USD 2.7%
Liabilities $20,232,000 USD 276%
Accumulated Other Comprehensive Income (Loss), Net of Tax $0 USD -100%
Retained Earnings (Accumulated Deficit) $189,326,000 USD -19%
Stockholders' Equity Attributable to Parent $6,641,000 USD -146%
Liabilities and Equity $13,591,000 USD -31%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $4,878,000 USD -3.5%
Net Cash Provided by (Used in) Financing Activities $10,742,000 USD -44%
Net Cash Provided by (Used in) Investing Activities $1,243,000 USD 91%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 15,437,410 shares 15%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $4,621,000 USD 277%
Deferred Tax Assets, Valuation Allowance $92,651,000 USD 4.7%
Deferred Tax Assets, Gross $92,662,000 USD 4.7%
Depreciation $58,000 USD -3.3%
Payments to Acquire Property, Plant, and Equipment $9,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $29,566,000 USD -116%
Lessee, Operating Lease, Liability, to be Paid, Year One $70,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $66,333,000 USD 6.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $5,173,000 USD -55%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%